Log In
BCIQ
Print this Print this
 

IV nemonoxacin

  Manage Alerts
Collapse Summary General Information
Company TaiGen Biopharmaceuticals Holdings Ltd.
DescriptionNon-fluorinated quinolone antibiotic topoisomerase inhibitor
Molecular Target Topoisomerase IV
Mechanism of ActionTopoisomerase IV inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPneumonia
Indication DetailsTreat community acquired bacterial pneumonia (CABP)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today